Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520051922> ?p ?o ?g. }
- W2520051922 endingPage "39" @default.
- W2520051922 startingPage "32" @default.
- W2520051922 abstract "This study explored anhedonia (lack of interest or pleasure in non-drug rewards) as a potentially modifiable individual difference associated with the effectiveness of Contingency Management (CM). It also tested the hypothesis that a dopaminergic drug, levodopa (L-DOPA), would improve the effectiveness of CM, particularly in individuals high in anhedonia. The study was a single-site, randomized, double-blind, parallel group, 12-week trial comparing L-DOPA with placebo, with both medication groups receiving voucher-based CM targeting cocaine-negative urines. Participants were N=85 treatment-seeking adults with CUD. Anhedonia was measured at baseline using a validated self-report measure and a progressive ratio behavioral measure. Treatment Effectiveness Score (TES) was defined as the total number of cocaine-negative urines submitted. Analyses based on Frequentist general linear models were not significant, but Bayesian analyses indicated a high probability (92.6%) that self-reported anhedonia was associated with poor treatment outcomes (lower TES). L-DOPA did not significantly improve outcomes, nor was the effect of L-DOPA moderated by anhedonia. While the study failed to replicate positive findings from previous studies of L-DOPA in combination with CM, it does provide preliminary evidence that anhedonia may be a modifiable individual difference associated with poorer CM outcomes." @default.
- W2520051922 created "2016-09-23" @default.
- W2520051922 creator A5005857896 @default.
- W2520051922 creator A5036001319 @default.
- W2520051922 creator A5042262661 @default.
- W2520051922 creator A5065012088 @default.
- W2520051922 creator A5076589191 @default.
- W2520051922 creator A5079831213 @default.
- W2520051922 date "2017-01-01" @default.
- W2520051922 modified "2023-09-23" @default.
- W2520051922 title "Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder" @default.
- W2520051922 cites W1511730593 @default.
- W2520051922 cites W1518219661 @default.
- W2520051922 cites W1523528129 @default.
- W2520051922 cites W1535680291 @default.
- W2520051922 cites W1934507450 @default.
- W2520051922 cites W1964544901 @default.
- W2520051922 cites W1967300857 @default.
- W2520051922 cites W1972376853 @default.
- W2520051922 cites W1979428966 @default.
- W2520051922 cites W1981114551 @default.
- W2520051922 cites W1982724855 @default.
- W2520051922 cites W1988606295 @default.
- W2520051922 cites W1991756001 @default.
- W2520051922 cites W1997504898 @default.
- W2520051922 cites W2007678775 @default.
- W2520051922 cites W2008441751 @default.
- W2520051922 cites W2012129255 @default.
- W2520051922 cites W2017026105 @default.
- W2520051922 cites W2019560014 @default.
- W2520051922 cites W2022174880 @default.
- W2520051922 cites W2027462039 @default.
- W2520051922 cites W2033060965 @default.
- W2520051922 cites W2035655846 @default.
- W2520051922 cites W2043955286 @default.
- W2520051922 cites W2045337988 @default.
- W2520051922 cites W2049882268 @default.
- W2520051922 cites W2061067944 @default.
- W2520051922 cites W2069296272 @default.
- W2520051922 cites W2070088299 @default.
- W2520051922 cites W2074184933 @default.
- W2520051922 cites W2074669819 @default.
- W2520051922 cites W2081771212 @default.
- W2520051922 cites W2083506326 @default.
- W2520051922 cites W2088522292 @default.
- W2520051922 cites W2092867693 @default.
- W2520051922 cites W2097456989 @default.
- W2520051922 cites W2098337487 @default.
- W2520051922 cites W2101540672 @default.
- W2520051922 cites W2108233388 @default.
- W2520051922 cites W2109565047 @default.
- W2520051922 cites W2110927923 @default.
- W2520051922 cites W2111308956 @default.
- W2520051922 cites W2113374471 @default.
- W2520051922 cites W2114006934 @default.
- W2520051922 cites W2114843987 @default.
- W2520051922 cites W2115867896 @default.
- W2520051922 cites W2123760635 @default.
- W2520051922 cites W2132245264 @default.
- W2520051922 cites W2139740546 @default.
- W2520051922 cites W2148297013 @default.
- W2520051922 cites W2148526944 @default.
- W2520051922 cites W2154278233 @default.
- W2520051922 cites W2159094421 @default.
- W2520051922 cites W2162839960 @default.
- W2520051922 cites W2165414412 @default.
- W2520051922 cites W2166462402 @default.
- W2520051922 cites W2166790971 @default.
- W2520051922 cites W2169255825 @default.
- W2520051922 cites W2169442707 @default.
- W2520051922 cites W2239774362 @default.
- W2520051922 cites W2322799063 @default.
- W2520051922 cites W2323913811 @default.
- W2520051922 cites W2412299009 @default.
- W2520051922 cites W4235825156 @default.
- W2520051922 cites W4252859303 @default.
- W2520051922 doi "https://doi.org/10.1016/j.jsat.2016.08.020" @default.
- W2520051922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5154907" @default.
- W2520051922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27646197" @default.
- W2520051922 hasPublicationYear "2017" @default.
- W2520051922 type Work @default.
- W2520051922 sameAs 2520051922 @default.
- W2520051922 citedByCount "67" @default.
- W2520051922 countsByYear W25200519222017 @default.
- W2520051922 countsByYear W25200519222018 @default.
- W2520051922 countsByYear W25200519222019 @default.
- W2520051922 countsByYear W25200519222020 @default.
- W2520051922 countsByYear W25200519222021 @default.
- W2520051922 countsByYear W25200519222022 @default.
- W2520051922 countsByYear W25200519222023 @default.
- W2520051922 crossrefType "journal-article" @default.
- W2520051922 hasAuthorship W2520051922A5005857896 @default.
- W2520051922 hasAuthorship W2520051922A5036001319 @default.
- W2520051922 hasAuthorship W2520051922A5042262661 @default.
- W2520051922 hasAuthorship W2520051922A5065012088 @default.
- W2520051922 hasAuthorship W2520051922A5076589191 @default.
- W2520051922 hasAuthorship W2520051922A5079831213 @default.
- W2520051922 hasBestOaLocation W25200519222 @default.